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Investigationofurinarymarkersasindicesofendogenousnitrosationandofgastriccanceretiology hasbeenamajor
focusofourwork. Aspartofthiseffort,studieshavebeencarriedoutonaColombianpopulationathighriskforgastric
cancer. Inthisgroup, nitrosoprolineexcretion washighlycorrelated withnitrateexcretioninthesubpopulation withad-
vancedgastricpathology, butnotincontrolsubpopulationswithmorenormalstomachs.Neitheruinary7-methylguanine
nor3-methyladenine wasstronglyrelatedtogastric pathology ortourinarynitrateornitrosoprolinelevels. Morerecently,
asevidencehasaccumulatedconcerningtheimportanceofnitricoxideasacellularmessenger, wehavebegunresearch
towarddevekopingmarkersforthepresenceofnitricoxideandforendogenousnitrosationviathiscompound. Nitricoxide
isfornedfromargiinebyactivatedendotheli cellsasamessengerforvasodlation. VWhaveshownthatproongedexercise
leadstoincreasedurinarynitrateandthatwhen '5N-arginine isingestedbyhumans, '5N-nitratelevelsincreasein24-hr
urine collections. Nitrosohydroxyethylglycine and 3-nitrotyrosine were evaluated as indices for the formation of N-
nitrosomorpholine andforthe nitrationofprotein, respectively, underexperimental conditions (e.g., immunostimula-
tion)expectedtoenhancenitric wsdefonnation. Nitrtrsinehasnotprovedusefulasabiomarkerfornitration/nitrosation
reactions in immunostimulated rats. Immunostimulationofratsfollowingadministrationofmorpholineled to increases
inurinary nitrateandnitrosohydroxyethylglycine. Thisprocedure, however, would not beappropriatefor humansdue
to thetoxicity ofmorpholine and thecarcinogenicity ofN-nitrosomorpholine.
Introduction
During the past several years we have made a major effort
toward validating the useofproteinadducts as dosimeters for in-
dividual exposure to carcinogens. Depending on the proteins
used, mostoften albuminorhemoglobin, theadductsreflectthe
average exposure over the weeks or months preceding the
analysis. Analysis of urine for evidence of exposure to xeno-
biotics, on theotherhand, typically reveals exposureduringthe
previous day or two, making these analyses complementary to
protein adduct analyses. Urine analysis has advantages (e.g.,
large amounts of sample are easily collected by noninvasive
means) anddrawbacks (e.g., excreted metabolites may represent
detoxication pathways and there may be very low levels ofthe
compounds of interest). In addition to these general charac-
teristics, a major focus inthe investigation ofurinary exposure
markers hasbeen the assessment ofDNAdamageviaquantita-
tionofDNArepairproducts, especially alkylatedbases, which
are excreted in urine.
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The most common application in this context has been the
measurementofurinary nitrosoaminoacidstoestimatelevelsof
gastricnitrosation. ThistechniquewasfirstreportedbyOhshima
and Bartsch (1), who proposed the use of N-nitrosoproline
(NPRO), anoncarcinogenicN-nitrosocompoundformedfrom
proline, which was naturally present in the human body and
whichcouldby safelyadministered insufficientamounts sothat
theN-nitrosoderivativecouldbeeasilyquantitated intheurine.
Thismethodhasbeenusedbyotherresearchers whohavecon-
firmed that nitrosamines are formed endogenously (2-5). In
humanstudies, urinary NPROlevelsincreasewhennitrateand
L-prolinedosesaregiven, andNPROexcretionreturns tobase-
line levels (14-30 nmole/day) when alarge dose (1 g) ofascor-
bicacid isgivenalong withtheL-proline. N-Nitrosoproline has
alsobeenused asabiomarker inlargerstudiesofpopulationsat
highriskforcancer. Luandco-workers, forexample, usedlevels
offoururinaryN-nitrosoaminoacids, includingNPRO, asanin-
dex of individual exposure to N-nitroso compounds or their
precursors ingested and/or formed endogenously in high- and
low-risk areas for esophageal cancer in northern China (6).
Whenthe subjects followedtheirnormaldietary patterns, NPRO
andnitratelevelsin24-hrurinesamplesweresignificantlyhigher
inthehigh-riskareathaninthelow-riskarea, thussupporting the
hypothesis thatexposure toN-nitrosocompoundscontributed to
thehigher risk. N-Nitrosothiazolidine carboxylicacid (NTCA),
first identifiedby Ohshima and co-workers (7), is also used asWISHNOKETAL.
anindicatorofendogenous nitrosation inboth ratsandhumans
(3,8,9). Theprecursor, thiazolidine-4-carboxylicacid (TCA) is
a condensation product ofcysteine and formaldehyde, and its
formation may represent a detoxification pathway for formal-
dehyde (10). N-Nitrosothiazolidine carboxylic acidis similarto
NPRO inthatitis nonvolatile, nontoxic, nonmutagenic, andnot
metabolized. Inaddition, NTCAisformedabout 1000-foldfaster
than NPRO(8,11)andisthereforepotentially moresensitivethan
NPRO as an indicator ofnitrosation.
These methods are based on the analyses ofnonmetabolized
N-nitroso compounds; the test compounds are thus noncar-
cinogenic and excreted quantitatively. In some specific cir-
cumstances, however, it has been possible to identify car-
cinogenic nitrosocompounds inhumanurine. A recentexample
ofthis wasthereportby Trickeretal. that severalnitrosamines
includingN-nitrosodimethylamine, N-nitrosodiethylamine, N-
nitrosopiperidine, andN-nitrosopyrrolidine weredetected inthe
urine ofparaplegics (12).
Inaddition to markers forendogenous nitrosation, there has
beenagrowinginterestinalkylatednucleicacidbasesasurinary
markers forDNAdamagebycarcinogenmetabolites. Although
7-methylguanine hadbeenmentionedinthiscontextasearly as
1967byCraddockandMagee(13), thisclassofcompoundswas
notpracticalasmarkersforhumanexposuretoalkylatingagents
until sufficiently sensitive techniques such as GC-MSbecame
routinelyavailable. FarmerandShukerandtheirco-workershave
now shown that it is indeed possible to monitorboth 7-methyl-
guanineand 3-methyladenine in humanpopulations (14-18).
We, alongwithmanyothergroups, havebeeninterestedboth
inthebiochemistry ofendogenous nitrosation andinthepossi-
ble involvementofN-nitroso compounds (especially when en-
dogenously formed) in human cancer. The remainder of this
reportsummarizes someofourapproaches totheseproblemsvia
quantitation ofvarious related substances in urineby methods
developed by us oradapted from others.
Analytical Methods
Nitrosoproline was quantitated as the methyl derivative by
GC-thermal energy analyzer (TEA) (1) and nitrate by an
automated method using theGriess reagent(19). Incorporation
of '5N into urinary nitrate was measured by GC-MS after
conversionofthenitrate tonitrobenzene (19). 3-Methyladenine
and7-methylguaninewereextractedfromurineandpurifiedwith
XAD-2 resin followed by bonded-phase extraction column
chromatography withcarboxylic acidcartridges (20). Theywere
then converted to the tert-butyldimethylsilyl derivatives and
quantitatedbyelectron-ionization GC-MS withthetrideuterio
analogs as internal standards. Nitrotyrosine (NTyr) and N-
nitrosohydroxyethylglycine were analyzed as the tert-butyldi-
methylsilyl derivatives by GC-TEA or GC-MS with either
positive chemical ionization ornegative ionchemical ionization
for NTyr and electron ionization for N-nitrosohydroxy-
ethylglycine (21).
Results and Discussion
Urinary Nitrosation andDNA-Damage Markers
for Gastric CancerRisk
Ourprojectsoflongestdurationinthisareaarefocusedonthe
risk factors leading to high rates ofgastric cancer in the high-
landsofColombia, thebiochemistryofendogenousnitratesyn-
thesis and endogenous nitrosation, and the possible relation-
ships, ifany,amongthem. IntheColombiangastriccancerstudy,
ahypothesisevolved in which nitrateinthedrinking waterwas
reduced to nitrite by salivary bacteria or by gastric bacteria
populating the achlorhydric stomach environment, which ac-
companiedthedevelopinggastricpathology(22,23). Thenitrite
was then presumably converted to nitrosating agents which in
turn converted compounds in the stomach with reactive -NH
bonds to carcinogenic N-nitroso compounds. This hypothesis
was strengthened when 4-chloro-6-methyoxyindole, which
formsadirect-acting mutagenwhennitrosated(24), wasisolated
from favabeans.
BecauseurinaryN-nitrosoproline levels couldbe used as in-
dices ofgastric nitrosation (1), andbecause urinary 3-methyl-
adenine(17,25), andtoalesserextent7-methylguanine (13,14),
reflected methylationofDNA, weevaluated thesecompounds,
aswellasnitrate, intheurineofalargegroupofpeoplefromthe
high-gastriccancerriskareaofColombia. Theobjectives were
todetermineifthelevelsofthesecompounds variedamong the
variouslevelsofgastricpathologyandifanyoftheindicesvaried
inconcert. Wewereparticularly interestedinwhetherincreased
levelsofnitratewerereflected in increased levelsofNPROand
3-methyladenine. Increased NPRO would suggest enhanced
gastric nitrosationandincreased3-methyladeninemightreflect
increased formation of alkylating intermediates, e.g., N-
nitrosodimethylamine. (3-Methyladenine-d3 arisesdirectly from
endogenously formed NDMA-d6 following administration of
dimethylamine-d6 and nitrite to ferrets; see below.)
Agroupof160randomlychosenpeoplewasassembled from
ahigh-riskareaintheNariinoregionofColombia. Information
aboutsmokingandalcoholconsumption wasobtainedby inter-
view. Onthebasisofhistologicalexaminationofgastricbiopsy
specimens, theparticipants wereassigned tooneofthe follow-
ing groups: normal gastric pathology, superficial gastritis,
chronic atrophic gastritis, chronic atrophic gastritis with in-
testinalmetaplasia, ordysplasia. Twenty-four-hoururinesam-
ples from each participant were analyzed for nitrate, N-
nitrosoproline, 3-methyladenine, and7-methylguanine. Linear
regressions werecarriedoutonallcombinationsofthedatasets.
Thetwo-samplet-testwasusedtodeterminedifferencesbetween
smokers andnonsmokers and fordrinkers and nondrinkers.
Therewasaweakbutsignificantcorrelation(r = 0.297,p =
0.0001, n = 160)betweenNPROandnitratefortheentirepopula-
tion which strengthened for the combined groups with meta-
plasiaanddysplasia (r = 0.60,p = 0.0001, n = 37). Therewere
noothernotablecorrelationsexcept aweakrelationshipbetween
NPRO and 3-methyladenine (r = 0.19, p = 0.02, n = 156).
Overallexcretionsofall fourcompounds werethesame, (i.e., no
statistically significant differences), for all gastric pathology
groups, but 3-methyladenine and 7-methylguanine levels were
higher for smokers than for nonsmokers.
3-Methyladenine from Endogenously Formed
N-Nitrosodimethylamine
As noted above, the appearance above dietary contributions
(18) of3-methyladenine inurineis anindicatorformethylation
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Table 1. 3-Methyladenine from endogenousformation of
N-nitrosodimethylamine.
Treatment 3-Methyladenine-d3, nga
Animal 1 None ND
DMA-d6 30
DMA-d6 + nitrite 150
Animal 2 None ND
DMA-d6 17
DMA-d6 + nitrite 60
Abbreviations: DMA, dimethylamine; ND, none detected.
aValues fortrideuterated3-methyladenine representthetotal amountexcreted
in one 24-hr period afterdosing.
ofDNA followed by excision repair. As part of astudy ofen-
dogenous formation ofNDMA inferrets, NDMA or its precur-
sor, dimethylamine, were labeled with stable isotopes to dis-
tinguish 3-methyladenine arising from metabolism of the
nitrosamine from thatarising fromother metabolic processes.
Theobjectives were todemonstratemethylationofDNAvia en-
dogenously formed NDMA and to compare DNAmethylation
with methylation of hemoglobin. Hexadeuterio-NDMA or
hexadeuterio-dimethylamine and sodium nitrite were admini-
stered to ferrets by various routes; urine was thenanalyzed for
[2H3C]3-methyladenine as anindexofDNAmethylation. Label-
ed 3-methyladenine was observed at levels corresponding to
priornitrosation yields of0.05-0.1 % following administration
oflabeleddimethylamineand nitrite(Table 1). GC-MSanalysis
confirmed the presence ofintactmethyl groups, indicating that
methylationoccurred viametabolismofendogenously formed
NDMA ratherthanby incorporationofdimethylamine into the
one-carbon pool. This was supported by related experiments
with '4C-labeled NDMA in which theanimal wastreated with
4-methylpyrazole, an inhibitor ofNDMA metabolism (27,28),
prior to administration of NDMA. In this case, no labeled
3-methyladenine wasobserved. Methylated hemoglobin, quan-
titated via GC-MS analysis of labeled methanol released on
hydrolysis (29), was observed in parallel with the 3-methyl-
adenine in all ofthese experiments.
Markers for Endogenous Formation
ofNitric Oxide
As theColombianprojectdeveloped, andwiththediscoveries
thatseveral cell types, includingbacteria(30,31), macrophages
(32,33), andendothelial cells (34), couldproducenitric oxide
undercertainconditions (Fig. 1), somemajorchanges inthink-
ingaboutendogenous nitrosation, previously believed to occur
primarily intheacidic stomach, became necessary. Reactionof
nitric oxide with oxygenproduces thenitrosating agents N203
and N204, the formerbeing anespecially effective nitrosating
agent at non-acidic pH (Fig. 1). These processes raised the
possibility that gastric nitrosation might occur at the elevated
gastric pH oftenobserved intheColombian high-risk group as
well atotherlocations inthebody. Itthusbecameofinterestto
develop, if possible, dosimeters for the formation in vivo of
nitricoxide oritsoxidationproductsandfortherelatednitrosa-
tion ofprecarcinogens atphysiological pH.
Inthe moststraightforwardexampleofthis, prolonged intense
exercise, expected to produce nitric oxide as a vasodilator in
response to increased oxygendemand, led to increased urinary
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FIGURE 1. Nitric oxide from various cell types. E. coli grownanaerobical-
ly in the presence of nitrate will reduce nitrite to nitric oxide (30,31).
MacrophagesstimulatedwithE. colilipopolysaccharideand/or-y-interferon
(32,33) and endothelial cells stimulated with bradykinin (34) oxidize
argininethrough acomplex pathway to produce nitric oxide.
nitrate excretion intwo human volunteers (21,35). In another
experiment, '5N-arginine wasingestedbyhumansandurinary
nitratewasanalyzedbyGC-MSforincorporationoflabel. IN-
Nitrate levels were elevated during the subsequent 24-hr,
demonstratingthatthearginine-nitric oxidepathway was valid
in humans (36).
3-Nitrotyrosine
Recently, Ohshima and co-workers (37) suggested that the
formation ofnitrotyrosine might be useful as an index for en-
dogenous nitrosation andpotentially for nitric oxide or its ox-
idation products; although not a urinary marker, our ex-
periments with NTyr were done concurrently with N-
nitroso(2-hydroxyethyl)-glycine and nitrate analyses for
stimulatednitricoxideproduction. Thiscompoundisespecially
appealing forhumanusebecausetheprecursorisnaturallypre-
sentinthebody. Nitrotyro-sineisreadilyformedinpeptidesand
proteinsafterincubationwithnitriteortetranitromethanein vitro
and in rats following treatment with tetranitromethane.
MetabolitesofanoraldoseofNTyrareexcretedinurine: about
44% as3-nitro-4-hydroxyphenylacetic acid(NHPA)andabout
5% as3-nitro-4-hydroxyphenylactic acid(NHPL); NHPAhas
also been detected in human urine (37), although its origin is
unknown.
FormationofNTyrin vivo frombiologically relevant nitro-
sating agents such as NO and NO,, has not yet been demon-
strated. In experiments with rats, no increase in NTyr was
detected abovebackground levels inglobin or plasma protein
followingadministrationofnitrite, although NTyrwasobserved
inbothplasmaproteinandglobinfollowing treatmentofblood
with nitric oxide. This was also true for animals treated with
lipopolysaccharide (LPS) or with Salmonella endotoxin,
althoughbothofthesetreatments resulted inelevated levelsof
urinary nitrate. Blood from ratstreatedwithtetranitromethane
(TNM)containedNTyrinplasmaproteinsas wellas inglobin.
Tetranitromethane iswell knownasaneffectivenitratingagent
forproteins. The reactionofnitritewithproteins, however, is
strongly dependentonpH; reactionatpH3.5 isover2000-fold
fasterthanreactionatpH7. FormationofNTyrinvivomayalso
behamperedby therapidreactionofnitriteornitricoxidewith
hemoglobin.
N-Nitroso-(2-hydroxyethyl)-glycine
N-Nitroso(2-hydroxyethyl)glycine (NHEG) was identified
by Hecht and Young (38) as the major urinary metabolite of
N-nitrosomorpholine (NMOR) in which the N-nitroso group
was retained; about 40% of an NMOR dose is excreted as
NHEG. Theamineprecursor, morpholine, isreadilynitrosated
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in vitro(39),bymacrophages inculture(40), andinthestomach
(41). N-nitrosomorpholine itself, however, is rapidly metabo-
lized in the wholeanimaland is, therefore, oflittledirectuseas
an indicatorofendogenous nitrosation.
N-Nitroso(2-hydroxyethyl)glycine has been used as a bio-
markerforendogenousnitrosation inLPS-stimulatedrats(35).
Lipopolysaccharide-induced immunostimulation isfollowedby
anincrease inurinaryexcretionofNHEG, almostcertainlydue
toenhancednitrosationofmorpholine. AfterLPStreatment, av-
erageurinaryNHEGrosefromabout24pmole/daytoabout 160
pmole/day, alongwitha25-foldincrease(fromabout514mole/day
toabout 130ymole/day)inurinarynitrate.N-Nitroso(2-hydroxy-
ethyl)glycinelevelswerenotincreasedfollowingadministration
ofeithernitrate ormorpholine (except inthelattercase forthat
arisingfromasmallamountofNMORpresentasanimpurityin
themorpholine); thenitrosatingagentappearstobethelimiting
reagentandtoarisedirectlyfromnitricoxideratherthanfromthe
recycling ofnitratetonitrosatingagents.
Alkylated adeninesotherthan3-methyladeninemaybeuseful
dosimeters inspecific situations, and3-methyladenine, as noted
intheColombianstudy, maybeuseful insituationswheredietary
variations are minimal or can be controlled. Although many
urinary markershavebeenuseful forelucidating mechanisms in
animal experiments, the most informative urinary indexes for
humanshavebeenthesimplest, e.g., nitrateandnitrosoproline.
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